• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
  • Nowy
Advances in Oncology, 2025

Advances in Oncology, 2025

9780443345791
937,39 zł
796,78 zł Zniżka 140,61 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 796,78 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Szczegóły produktu
Elsevier
103163
9780443345791
9780443345791

Opis

Rok wydania
2025
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
191 x 235
Waga (g)
450
  • SECTION I: RADIATION ONCOLOGY
    Adaptative Radiation Therapy
    Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders
    SECTION II: SURGICAL ONCOLOGY
    Neoadjuvant Treatment Strategies in Gastrointestinal Stromal Tumors
    Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors
    Contemporary Approaches to Adrenocortical Carcinoma
    SECTION III: MEDICAL ONCOLOGY
    State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer
    Integration of Early Palliative Care in Personalized Cancer Care
    Treatment Advances in Small Cell Lung Cancer
    SECTION IV: GYNECOLOGIC ONCOLOGY
    Emerging Therapeutic Targets for Platinum Resistant Ovarian Cancer
    Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer
    SECTION V: PEDIATRIC ONCOLOGY
    Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions
    Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations
    Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors
    SECTION VI: NEURO-ONCOLOGY
    Treatment of Isocitrate Dehydrogenase Mutant Gliomas
    Exosomes in Glioma: Diagnostic and Therapeutic Potentials
    Maximal Extent of Resection, Including Supramaximal Resection, for Diffuse Gliomas
    SECTION VII: HEMATOLOGICAL ONCOLOGY
    Will Triplet Therapy Become Standard of Care in Acute Myeloid Leukemia?
    Current and Future Approaches for the Treatment of Plasma Cell Leukemia
    Germline Testing in Hematopoietic Malignancies: Whom to Test, When, How, and Why
    SECTION VIII: URO-ONCOLOGY
    Bladder-Sparing Approaches in Muscle Invasive Bladder Cancer
    Adjuvant Therapy in Renal Cell Carcinoma: Current Landscape and Future Directions
    Poly-ADP Ribose Polymerase Inhibitors and Combinations in Metastatic Prostate Cancer
    SECTION IX: GASTROINTESTINAL ONCOLOGY
    The Potential Role of Circulating Tumor DNA as a Tool in the Management of Gastrointestinal Malignancies
    How I Treat Advanced Biliary Cancer
    Disparities Along the Cancer Care Continuum: The Role of Social Drivers of Health on Gastrointestinal Malignancies
Komentarze (0)